The Pfizer-BioNTech COVID-19 vaccine gets Emergency Use Authorization for booster doses in certain individuals; A smaller vaccine dose appears safe and effective in children; A survey sheds light on parents’ thoughts on child COVID vaccination; Janssen share booster data for their vaccine; Remdesivir efficacy data in COVID-19 patients, And Opzelura is approved for atopic dermatitis.
A 5-month-old Hispanic infant presents for evaluation of a rash involving his arms and trunk that has worsened over the past month. Can you make the correct diagnosis?
The Food and Drug Administration has approved Opzelura (ruxolitinib) cream for the short-term and noncontinuous chronic treatment of mild to moderate atopic dermatitis in nonimmunocompromised patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable. The approval was based on data…
The application is supported by data from the phase 2/3 RELATIVITY-047 trial.
The expanded approval was based on data from adequate and well-controlled phase 3 studies as well as an open-label safety study in adolescents.
Patients with acne prescribed isotretinoin less likely to engage in suicidal behavior than those treated with antibiotics only or those in the general population
A 24-year-old woman presents with concerns about a rash on her chest that she first noticed 3 days ago. Can you make the correct diagnosis?
Rilzabrutinib is an oral Bruton tyrosine kinase inhibitor currently in development for a number of immune-mediated diseases.
A 43-year-old Hispanic woman presents for evaluation of white spots that were first noted on the back of her hands approximately 3 months prior to evaluation and have spread to her arms and face. Can you make the correct diagnosis?
According to studies, Prelivia was found to increase tissue oxygenation by 28% and decrease pressure induced tissue damage by 80%.
